Aligos Therapeutics News - ALGS

Company Name	Stock Ticker Symbol	Market	Type
Aligos Therapeutics Inc	ALGS	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.0321	-3.92%	0.7859	19:46:11

Open Price	Low Price	High Price	Close Price	Prev Close
0.818	0.77	0.8341	0.782	0.818

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	16:05	GLOBE	Aligos Therapeutics Presents Positive Clinical Data at..
4/25/2024	08:00	GLOBE	Aligos Therapeutics Mourns the Passing of MASH Industry..
4/09/2024	08:00	GLOBE	Aligos Therapeutics to Participate in the Piper Sandler..
4/03/2024	08:00	GLOBE	Aligos Therapeutics Announces First Subjects Dosed in the..
3/27/2024	08:00	GLOBE	Aligos Therapeutics Presents Positive Clinical Data at APASL..
3/18/2024	08:00	GLOBE	Aligos Therapeutics Announces the Initiation of the Phase 2a..
3/12/2024	16:05	GLOBE	Aligos Therapeutics Reports Recent Business Progress..
3/05/2024	16:05	GLOBE	Aligos Therapeutics to Announce 4th Quarter 2023 Financial..
3/04/2024	17:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/04/2024	17:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	17:35	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	17:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	17:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/26/2024	08:00	GLOBE	Aligos Therapeutics To Participate in the Leerink Partners..
2/20/2024	08:00	GLOBE	Aligos Therapeutics to Host KOL Event to Discuss Phase 2a..
2/13/2024	08:00	GLOBE	Aligos Therapeutics Strengthens Finance Leadership Team with..
1/30/2024	07:04	EDGAR2	Form SC TO-I - Tender offer statement by Issuer
1/25/2024	06:12	EDGAR2	Form SC TO-C - Written communication relating to an issuer..
1/25/2024	06:06	EDGAR2	Form 8-K - Current report
11/28/2023	16:01	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/22/2023	16:05	EDGAR2	Form 8-K - Current report
11/17/2023	16:38	EDGAR2	Form S-3 - Registration statement under Securities Act of..
11/15/2023	16:01	EDGAR2	Form 8-K - Current report
11/07/2023	12:03	EDGAR2	Form D - Notice of Exempt Offering of Securities
11/02/2023	16:23	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	16:08	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
11/02/2023	16:05	EDGAR2	Form 8-K - Current report
10/25/2023	17:05	EDGAR2	Form 8-K - Current report
10/18/2023	08:45	EDGAR2	Form 8-K - Current report
9/12/2023	16:08	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/12/2023	16:07	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/12/2023	16:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/07/2023	16:01	EDGAR2	Form 8-K - Current report
8/03/2023	16:21	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/2023	16:05	EDGAR2	Form 8-K - Current report
8/01/2023	16:52	EDGAR2	Form 8-K - Current report
7/25/2023	16:02	EDGAR2	Form 8-K - Current report
7/21/2023	16:13	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..